These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30385708)

  • 1. Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set.
    Elmamoun M; Leung YY; O'Sullivan D; Steinkoenig I; Chandran V; Gladman DD; FitzGerald OM; Orbai AM; Eder L
    J Rheumatol; 2019 Mar; 46(3):266-273. PubMed ID: 30385708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
    Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
    J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
    Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
    Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
    Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
    Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic Arthritis Sonographic Enthesitis Instruments: A Systematic Review of the Literature.
    Elalouf O; Bakirci Ureyen S; Touma Z; Anderson M; Kaeley GS; Aydin SZ; Eder L
    J Rheumatol; 2019 Jan; 46(1):43-56. PubMed ID: 30008458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review.
    Ruof J; Stucki G
    J Rheumatol; 1999 Apr; 26(4):966-70. PubMed ID: 10229429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.
    Duarte-García A; Leung YY; Coates LC; Beaton D; Christensen R; Craig ET; de Wit M; Eder L; Fallon L; FitzGerald O; Gladman DD; Goel N; Holland R; Lindsay C; Maxwell L; Mease P; Orbai AM; Shea B; Strand V; Veale DJ; Tillett W; Ogdie A
    J Rheumatol; 2019 Aug; 46(8):996-1005. PubMed ID: 30770518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
    Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
    J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review.
    Vercoutere W; Thevissen K; Bombardier C; Landewé RB
    J Rheumatol Suppl; 2011 Mar; 87():15-9. PubMed ID: 21364051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory findings in psoriatic arthritis.
    Punzi L; Podswiadek M; Oliviero F; Lonigro A; Modesti V; Ramonda R; Todesco S
    Reumatismo; 2007; 59 Suppl 1():52-5. PubMed ID: 17828345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite Outcome Measures for Psoriatic Arthritis: OMERACT and 3 and 4 Visual Analog Scale Progress in 2023.
    Leung YY; Gladman DD; Orbai AM; Tillett W
    J Rheumatol; 2024 Oct; 51(Suppl 2):80-83. PubMed ID: 39009401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative.
    Antony A; Holland R; D'Agostino MA; Maksymowych WP; Bertheussen H; Schick L; Goel N; Ogdie A; Orbai AM; Højgaard P; Coates LC; Strand V; Gladman DD; Christensen R; Leung YY; Mease P; Tillett W
    Semin Arthritis Rheum; 2021 Apr; 51(2):367-386. PubMed ID: 33601193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.